Chen Anderson A

Show results for

Unknown (4159)
Proteomics (46)
Transcriptomics (18)
Genomics (14)
Metabolomics (11)
Genomic (1)

Organisms

Homo sapiens (51)
Mus musculus (12)
Chlamydomonas reinhardtii (1)
Saccharomyces cerevisiae (1)

Organisms

Mus musculus (6)
Homo sapiens (3)
gut metagenome (1)

Repository

pride (43)
biostudies-arrayexpress (18)
MetaboLights (11)
ENA (11)
EGA (3)
MassIVE (2)
dbGaP (1)
PanoramaPublic (1)

Tissue

Cell culture (13)
Permanent cell line cell (7)
Epithelial cell (6)
Early embryonic cell (4)
HEK-293T cell (3)
Cardiac muscle cell (2)
Cell suspension culture (2)
HeLa cell (2)
Heart (2)
Kidney (2)
Embryo (1)
Esophagus (1)
Fibroblast (1)
Lung (1)
MCF-10A cell (1)
Mesothelium (1)
Ovarian surface epithelial cell (1)
Peritoneal cavity (1)
T cell (1)
Uterine endometrium (1)
Whole body (1)

Disease

Breast cancer (4)
Cervix carcinoma (4)
Disease free (4)
Barrett's esophagus (1)
Cardiovascular system disease (1)
Lung adenocarcinoma (1)
Peritoneal mesothelioma (1)

Technology Type

Mass Spectrometry (43)
Affinity purification coupled with mass spectrometry proteomics (20)
Shotgun proteomics (12)
Bottom-up proteomics (9)
Mass spectrometry (8)
NMR spectroscopy (3)
Data-dependent acquisition (3)
Data-independent acquisition (3)
Affinity proteomics (2)
Gel-based experiment (1)
Top-down proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
MS Imaging - (2)
Orbitrap Fusion Lumos (1)
Q Exactive HF-X (1)
Agilent (1)
Liquid Chromatography MS - alternating (1)
Liquid Chromatography MS - alternating – hilic (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS – negative - reverse phase (1)
Nuclear Magnetic Resonance (NMR) (1)
Nuclear Magnetic Resonance (NMR) - (1)
Varian (1)
Xevo G2-XS QTOF (Waters) (1)

Publication Date

2023 (8)
2016 (7)
2025 (7)
2019 (7)
2017 (5)
2024 (5)
2022 (5)
2021 (4)
2014 (3)
2011 (3)
2010 (3)
2026 (3)
2020 (3)
2018 (3)
2015 (2)
2007 (2)
2012 (1)
2009 (1)
2008 (1)

CHEBI ID

CHEBI:17368 (6)
CHEBI:16335 (5)
CHEBI:16737 (5)
CHEBI:17568 (5)
CHEBI:18257 (5)
CHEBI:32816 (5)
CHEBI:15318 (4)
CHEBI:15741 (4)
CHEBI:15756 (4)
CHEBI:15891 (4)
CHEBI:16027 (4)
CHEBI:16196 (4)
CHEBI:16235 (4)
CHEBI:16449 (4)
CHEBI:16556 (4)
CHEBI:16566 (4)
CHEBI:16704 (4)
CHEBI:16708 (4)
CHEBI:16750 (4)
CHEBI:16919 (4)
CHEBI:17154 (4)
CHEBI:17361 (4)
CHEBI:17509 (4)
CHEBI:17562 (4)
CHEBI:17596 (4)
CHEBI:17748 (4)
CHEBI:17895 (4)
CHEBI:17964 (4)
CHEBI:27226 (4)
CHEBI:30746 (4)

Metabolite Name

Hypoxanthine (6)
Creatinine (5)
Adenosine (4)
Creatine (4)
Guanine (4)
Guanosine (4)
Inosine (4)
L-Tyrosine (4)
Niacinamide (4)
Ornithine (4)
Pipecolic acid (4)
Sphinganine (4)
Taurine (4)
Uracil (4)
Uric acid (4)
Xanthine (4)
1-Methylnicotinamide (3)
4-Hydroxybenzoic acid (3)
5'-Methylthioadenosine (3)
5-Methyltetrahydrofolic acid (3)
Adenine (3)
Aminoadipic acid (3)
Benzaldehyde (3)
Carnosine (3)
Cholesterol (3)
Choline (3)
Cinnamaldehyde (3)
Cyclic GMP (3)
Cysteic acid (3)
Cytidine (3)

First Public Date

2019 (3)
2025 (2)
2024 (2)
2013 (2)
2021 (1)
2018 (1)

Modification

15.994915 (4)
57.021464 (4)
71.037114 (3)

Study type

Transcription profiling by array (17)
Comparative genomic hybridization by array (1)

Release Date

2021 (387)
2023 (361)
2024 (357)
2022 (353)
2025 (336)
2020 (316)
2018 (298)
2019 (251)
2016 (250)
2017 (244)
2015 (236)
2014 (176)
2013 (132)
2012 (118)
2011 (99)
2010 (79)
2026 (54)
2009 (51)
2008 (25)
2007 (21)
2006 (12)
2005 (4)
2004 (4)
2003 (3)
2002 (3)
1999 (3)
2001 (1)
2000 (1)
1998 (1)

Lab affiliation

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA (5)
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (4)
Experimental Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA (4)
1) Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX 77030, USA 2) Proteomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX 77030, USA 3) Metabolomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX 77030, USA (2)
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center (2)
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center (2)
University of Wisconsin School of Medicine and Public Health (2)
Assistant Professor, Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center (1)
Assistant Professor, Department of Chemistry, The ScrippsResearch Institute (1)
Chair of Proteomics and Bioanalytics, Technical University of Munich, Bavaria, Germany (1)
Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA (1)
Department of Chemistry and Chemical Biology (1)
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1)
Department of Laboratory Medicine, UCSF (1)
Department of Molecular and Cellular Oncology, MD Anderson Cancer Center, Houston, TX USA (1)
Department of Systems Biology, Laboratory for Systems Pharmacology, Harvard Medical School, Boston MA, USA (1)
Department of Systems Biology, Laboratory of Systems Pharmacology, Harvard Medical School, Boston MA, 02115 (1)
Department of Systems Biology, Laboratory of Systems Pharmacology, Harvard Medical School, Boston MA, USA (1)
Donald Danforth Plant Science Center, St. Louis, Missouri 63132 (1)
Experimental Radiation Oncology department, The University of Texas MD Anderson Cancer Center (1)
Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center (1)
Experimental Radiation Oncology, The University of Texas, MD Anderson Cancer Center (1)
Harvard Department of Stem Cell and Regenerative Biology Cambridge, MA 02138, USA (1)
Laboratory for Biological Mass Spectrometry, Biosciences Institute, Newcastle University, Newcastle-upon-Tyne, NE2 4HH, UK (1)
MD Anderson Cancer Center (1)
SULFAGING group; Leibniz Institute for Analytical Sciences - ISAS - eV. Dortmund, GERMANY (1)
UT MD Anderson Cancer Center (1)
University of California San Diego (1)
Vancouver Prostate Centre (1)

Tags

xref:PubMed:31548395 (3)
xref:PubMed:39298484 (2)
xref:PubMed:23530127 (2)
xref:PubMed:29170441 (1)

Previous page
1 / 425
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 425
Next page

Sort by:

Relevance

Page size

Disorder-driven non-Anderson transition in a Weyl semimetal.

Not available

S-EPMC12541400 | biostudies-literature

Anderson Localized Plasmon in Graphene with Random Tensile-Strain Distribution.

Not available

S-EPMC6446603 | biostudies-literature

Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update.

Not available

S-EPMC6904523 | biostudies-literature

Genomic characterization of the MPNST

Malignant peripheral nerve sheath tumor (MPNST) is a rare sarcoma that lacks effective therapeutic strategies. By characterizing recurrent gene copy number aberrations, we gain insight into the most altered pathways with the purpose of scanning possible therapeutic targets. We conducted a microarray...

ORGANISM(S): Homo sapiens

2011-11-26 | E-GEOD-33881 | biostudies-arrayexpress

Anderson localization of electrons in single crystals: Li (x) Fe(7)Se(8).

Not available

S-EPMC4788481 | biostudies-literature

Deciphering the metabolic perturbation in hepatic alveolar echinococcosis: a 1H NMR-based metabolomics study

BACKGROUND: Hepatic alveolar echinococcosis (HAE) is caused by the growth of Echinococcus multilocularis larvae in the liver. It is a chronic and potentially lethal parasitic disease. Early stage diagnosis for this disease is currently not available due to its long asymptomatic ...

2021-08-03 | MTBLS981 | MetaboLights

Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.

Not available

S-EPMC11094415 | biostudies-literature

Quantum Magnetic Properties in Perovskite with Anderson Localized Artificial Spin-1/2.

Not available

S-EPMC5980209 | biostudies-literature

Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence.

Not available

S-EPMC12799554 | biostudies-literature

Mutant p53 interactome study with IP-MS

Inactivating TP53 mutations lead to a loss of function of p53, but can also often result in oncogenic gain-of-function (GOF) of mutant p53 (mutp53) proteins which promote tumor development and progression. The GOF activities of TP53 mutations are well documented, but the mechanisms involved remain p...

ORGANISM(S): Homo sapiens (Human)

2023-11-27 | PXD047094 | Pride

Previous page
1 / 425
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 425
Next page

Sort by:

Relevance

Page size

4249 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

BACKGROUND: Hepatic alveolar echinococcosis (HAE) is caused by the growth of Echinococcus multilocularis larvae in the liver. It is a chronic and potentially lethal parasitic disease. Early stage diagnosis for this disease is currently not available due to its long asymptomatic ...

OmicsDI is part of the ELIXIR infrastructure

Tweets